siRNA, Anti-Human ACLY, LNA(CAT#: SIRGT04031WQ-LNA)

The product SIRGT04031WQ-LNA is a type of small interfering RNA (siRNA) that targets ACLY gene and regulates the expression of gene. The siRNA interferes with the expression of ACLY gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001096.2; NM_001303274.1; NM_001303275.1; NM_198830.1
Alternative Names ACL; ATPCL; CLATP
Related Diseases Acrocallosal Syndrome, Soft Palate Cancer
Purification HPLC
Target Gene
Gene ID 47
Uniprot ID P53396

Related Products